IPSC haplobanks are repositories of stem cell lines selected for diverse HLA types, enabling immune-matched, off-the-shelf therapies. They support efficient, standardized manufacturing of cell-based treatments while reducing rejection risks and advancing the accessibility of personalized and regenerative medicine. https://www.xelleratherapeutics.com/services/custom-manufacturing-services/